Product image of Lamosynt (Lamotrigine) supplied by GNH India

Lamosynt

Active Ingredient:
Lamotrigine
Origin:
EU

Lamosynt (Lamotrigine)

Lamotrigine, the active ingredient in Lamosynt, is an anticonvulsant presented as an oral tablet for oral use. It is indicated for the treatment of epilepsy, the maintenance therapy of bipolar disorder, and the prevention of migraine attacks in suitable patients.

GNH India supplies Lamosynt as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable access to quality‑assured medicines across regulated markets. The company adheres to stringent quality standards, ensures proper documentation, and supports customers with logistics, regulatory compliance, and post‑delivery service.

Manufacturer / TM Owner

Codal Synto Ltd

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Lamotrigine is used in the management of several neurological and psychiatric conditions.

  • Epilepsy: Reduces seizure frequency and severity in focal and generalized seizure types, supporting long‑term seizure control.
  • Bipolar disorder: Provides mood stabilization and decreases the risk of depressive episodes, helping maintain long‑term mood balance.
  • Migraine prevention: Lowers the number of migraine attacks when used as prophylaxis, contributing to improved quality of life.
  • Adjunct therapy in refractory epilepsy: Enhances seizure control when combined with other antiepileptic agents.

How It Works

  • Lamotrigine exerts its antiepileptic and mood‑stabilizing effects primarily by inhibiting voltage‑gated sodium channels in neuronal membranes. This blockade reduces the rapid influx of sodium ions during depolarization, stabilizing neuronal excitability and decreasing the release of excitatory neurotransmitters such as glutamate. The resulting modulation of synaptic transmission underlies its efficacy in seizure control, bipolar disorder maintenance, and migraine prophylaxis.

Side Effects

Lamotrigine may be associated with a range of adverse reactions, which are classified by frequency and severity.

Common Side Effects

  • Rash: mild skin irritation or erythema.
  • Headache: transient head discomfort.
  • Dizziness: light‑headed sensation.
  • Nausea: mild gastrointestinal upset.
  • Insomnia: difficulty falling or staying asleep.
  • Blurred vision: temporary visual disturbances.

Serious or Rare Side Effects

  • Stevens‑Johnson syndrome: severe skin reaction requiring immediate medical attention.
  • Toxic epidermal necrolysis: life‑threatening skin detachment.
  • Aseptic meningitis: inflammation of the meninges without infection.
  • Hematologic abnormalities: such as agranulocytosis or aplastic anemia.
  • Hepatic dysfunction: elevated liver enzymes or hepatitis.
  • Severe hypersensitivity: including anaphylaxis.

Precautions & Warnings

When prescribing lamotrigine, clinicians should consider several precautionary measures to minimize risks and ensure safe use.

  • Initiate therapy at low dose: start with a low dose and titrate gradually to reduce rash risk.
  • Monitor skin reactions: observe for any rash and discontinue if severe.
  • Assess hepatic function: adjust dosing in patients with liver impairment.
  • Review concomitant medications: avoid drugs that significantly alter lamotrigine levels.
  • Pregnancy counseling: discuss risks as lamotrigine is classified as Category D.
  • Avoid abrupt discontinuation: taper dose to prevent seizure recurrence.
  • Store at ambient temperature: keep below 25 °C in the original packaging, protected from moisture.

Avoid Interactions

Lamotrigine interacts with several medicines, influencing its plasma concentration or increasing the risk of adverse events.

Major Interactions (Avoid)

  • Valproic acid: markedly increases lamotrigine levels, requiring dose reduction.
  • Carbamazepine: significantly decreases lamotrigine levels, potentially reducing efficacy.

Moderate Interactions (Monitor Closely)

  • Oral contraceptives: may lower lamotrigine concentrations, necessitating dose adjustment.
  • Phenobarbital: reduces lamotrigine levels, monitor seizure control.
  • Phenytoin: decreases lamotrigine concentrations, watch for breakthrough seizures.
  • Serotonergic agents: may increase risk of serotonin syndrome, observe for symptoms.

Frequently Asked Questions

Lamosynt contains lamotrigine, which is prescribed to control seizures in epilepsy, to maintain mood stability in bipolar disorder, and to prevent migraine attacks when used as a prophylactic agent.

Lamotrigine works by blocking voltage‑gated sodium channels on neurons, which reduces the rapid influx of sodium ions during depolarisation. This stabilises neuronal firing and lowers the release of excitatory neurotransmitters such as glutamate, helping to control seizures and mood swings.

The dose of lamotrigine is individualised. A qualified prescriber determines the starting dose, titration schedule, and maintenance dose based on the patient’s condition, age, concomitant medicines and response to therapy.

Lamotrigine is classified as Pregnancy Category D, indicating evidence of risk to the fetus. It should only be used if the potential benefit justifies the risk. Limited data are available for breastfeeding, and a clinician should weigh the benefits against possible infant exposure.

To place an order, submit an enquiry on the Lamosynt product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Compared with older agents such as carbamazepine, lamotrigine has a lower risk of drug‑induced hyponatraemia and fewer cognitive side effects, but it carries a higher risk of skin rash. Its broad spectrum covers both focal and generalized seizures, and it also offers mood‑stabilising benefits not seen with many other anticonvulsants.

Lamosynt tablets should be stored at ambient temperature, below 25 °C, in the original container to protect them from moisture and light. Keep the product out of reach of children and do not use after the expiry date.

Lamosynt is taken orally as a tablet. It should be swallowed whole with water, with or without food, according to the prescriber’s instructions. The tablet should not be crushed, chewed, or split unless specifically advised.

The most serious risks include severe skin reactions such as Stevens‑Johnson syndrome or toxic epidermal necrolysis, aseptic meningitis, and rare blood disorders like agranulocytosis. Prompt medical attention is required if any signs of these conditions appear.

Lamosynt is contraindicated in patients with a known hypersensitivity to lamotrigine or any of its excipients. Caution is also advised for individuals with severe hepatic impairment, as the drug’s metabolism may be significantly altered.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Lamotrigine

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT